ATE182468T1 - Bistriazene als chemotherapeutische mittel - Google Patents

Bistriazene als chemotherapeutische mittel

Info

Publication number
ATE182468T1
ATE182468T1 AT91910672T AT91910672T ATE182468T1 AT E182468 T1 ATE182468 T1 AT E182468T1 AT 91910672 T AT91910672 T AT 91910672T AT 91910672 T AT91910672 T AT 91910672T AT E182468 T1 ATE182468 T1 AT E182468T1
Authority
AT
Austria
Prior art keywords
compounds
bistriazene
cancer
bistriazenes
chemotherapeutic agents
Prior art date
Application number
AT91910672T
Other languages
English (en)
Inventor
Christopher J Michejda
Jeffrey J Blumenstein
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Application granted granted Critical
Publication of ATE182468T1 publication Critical patent/ATE182468T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/22—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond containing chains of three or more nitrogen atoms with one or more nitrogen-to-nitrogen double bonds
    • C07C245/24—Chains of only three nitrogen atoms, e.g. diazoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91910672T 1990-05-24 1991-05-22 Bistriazene als chemotherapeutische mittel ATE182468T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52791590A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
ATE182468T1 true ATE182468T1 (de) 1999-08-15

Family

ID=24103474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91910672T ATE182468T1 (de) 1990-05-24 1991-05-22 Bistriazene als chemotherapeutische mittel

Country Status (10)

Country Link
US (2) US5672593A (de)
EP (1) EP0531419B1 (de)
JP (1) JPH05506452A (de)
AT (1) ATE182468T1 (de)
AU (1) AU642273B2 (de)
CA (1) CA2083148C (de)
DE (1) DE69131481T2 (de)
DK (1) DK0531419T3 (de)
ES (1) ES2134778T3 (de)
WO (1) WO1991017753A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808038A (en) * 1990-05-24 1998-09-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bistriazenes as chemotherapeutic agents
WO1993009089A1 (en) * 1991-10-31 1993-05-13 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Bistriazenes as chemotherapeutic agents
US5548070A (en) * 1993-07-22 1996-08-20 Wacker-Chemie Gmbh Organosilicon compounds having triazene groups
DE19508076C2 (de) * 1995-03-08 1998-04-30 Csb Syst Software Entwicklung Schaltungsanordnung zur Integration eines Sprachsystems in EDV-Systeme und Telefonanlagen, die an das öffentliche Telefonnetz angeschlossen sind
ZA973642B (en) * 1996-04-26 1997-11-25 Merck & Co Inc DNA vaccine formulations.
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
AU2002331897A1 (en) 2001-09-27 2003-04-07 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
CA2481504C (en) 2002-04-08 2011-08-23 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
US7987056B2 (en) 2004-09-20 2011-07-26 The Regents Of The University Of Colorado, A Body Corporate Mixed-library parallel gene mapping quantitative micro-array technique for genome-wide identification of trait conferring genes
AR073060A1 (es) 2008-08-14 2010-10-13 Arana Therapeutic Ltd Anticuerpos anti-il-12/il-23
EP2557075A1 (de) 2011-08-09 2013-02-13 Trin Therapeutics GmbH Neue Triazenverbindungen zur Behandlung von Krebs
CN103906835A (zh) 2011-10-25 2014-07-02 先锋国际良种公司 改变植物细胞壁组成以改善生物燃料生产和青贮饲料可消化性的方法
WO2020121304A1 (en) * 2018-12-10 2020-06-18 Ariel Scientific Innovations Ltd. Therapeutic conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138521A (en) * 1960-10-04 1964-06-23 Gen Aniline & Film Corp Fungicidal method
CH482789A (de) * 1967-03-16 1969-12-15 Ciba Geigy Verfahren zur Herstellung neuer Disazofarbstoffpigmente
DE1793115A1 (de) * 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
DE3426644A1 (de) * 1984-07-19 1986-02-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, 6900 Heidelberg N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether
US4923970A (en) * 1988-03-28 1990-05-08 Bionetics Research, Inc. Substituted 1-(2-chloroethyl)-3-acyl-3-alkyltriazenes

Also Published As

Publication number Publication date
AU8089791A (en) 1991-12-10
JPH05506452A (ja) 1993-09-22
DE69131481T2 (de) 1999-11-25
US5672593A (en) 1997-09-30
CA2083148A1 (en) 1991-11-25
DK0531419T3 (da) 1999-11-29
WO1991017753A1 (en) 1991-11-28
EP0531419B1 (de) 1999-07-28
ES2134778T3 (es) 1999-10-16
US5731301A (en) 1998-03-24
DE69131481D1 (de) 1999-09-02
EP0531419A1 (de) 1993-03-17
EP0531419A4 (en) 1994-04-06
CA2083148C (en) 2002-01-01
AU642273B2 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
ATE182468T1 (de) Bistriazene als chemotherapeutische mittel
DE69535805D1 (de) Neue Carbamate- und Harnstoffderivate als Mittel gegen Multidrugresistenz
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
TR200100918T2 (tr) Aril ve heteroaril sübstitüentli üreler kullanılarak RAF kinazın inhibe edilmesi
MX9605665A (es) Bis (resorcinil) triazinas.
KR960004344A (ko) 6원 질소 함유 헤테로아릴-옥사졸리디논
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
DE68911742D1 (de) Substituierte flavonoide Verbindungen, ihre Salze, ihre Herstellung und die enthaltende Arnzeizusammensetzungen.
LU88317I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
ATE102604T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
JPS57123109A (en) Local cosmetic medicine for treating highly greasy hair and seborrheic skin
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
AU7116781A (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
DE59409456D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
BR9106272A (pt) Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo
ATE189207T1 (de) Bistriazene als chemotherapeutische wirkstoffe
DE69311123D1 (de) Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe
DE68925609D1 (de) Esterderivate von mit Alkohol modifizierten Siloxanen und kosmetische Zusammensetzungen, die diese Derivate enthalten
DE58903821D1 (de) Verwendung von addukten von 1,2-butylenoxid an aminen als schmierstoffe und schmierstoffe, diese addukte enthaltend.
KR890017363A (ko) 스트로빌루린 유도체, 이들의 제법 및 용도

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee